Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study.

Ophthalmology·2026
Same author

Validating the Ask Suicide-Screening Questions in Amharic for Ethiopian paediatric patients.

Journal of child and adolescent mental health·2026
Same author

Acute exposure to fine ambient particulate matter and pulmonary exacerbations in cystic fibrosis: A case-crossover study.

Atmospheric Environment: X·2026
Same author

A neural-symbolic AI agent system for biomedical concept mapping.

NPJ digital medicine·2026
Same author

Developing RxNorm Extension: A Step Toward Global Drug Data Harmonization in Observational Drug Research.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

The impact of after-death communications on grief and meaning-making among the bereaved: A qualitative systematic review.

Death studies·2026
Same journal

A Drug-Environment Interaction Between PM<sub>2</sub> <sub>.5</sub> Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults.

Pharmacoepidemiology and drug safety·2026
Same journal

Association Between Socioeconomic Conditions and Biologic Prescriptions for Inflammatory Bowel Diseases in the Brazilian Public Healthcare System: An Ecological Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial Emulation.

Pharmacoepidemiology and drug safety·2026
Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Statistical visualization for assessing performance of methods for safety surveillance using electronic databases.

Xiaochun Li1, Siu Hui, Patrick Ryan

  • 1Division of Biostatistics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. xiaochun@iupui.edu

Pharmacoepidemiology and Drug Safety
|February 15, 2013
PubMed
Summary
This summary is machine-generated.

This study developed a heatmap visualization tool to help researchers explore statistical method parameters for drug safety and comparative effectiveness studies. The tool aids in understanding how different settings impact study design and analysis, improving predictive properties.

Related Experiment Videos

Last Updated: May 14, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Pharmacoepidemiology
  • Biostatistics
  • Health Informatics

Background:

  • The efficacy of drug safety surveillance and comparative effectiveness studies relies heavily on robust design, analysis, and data quality.
  • The Observational Medical Outcomes Partnership (OMOP) has developed a suite of statistical methods with numerous parameters for diverse study designs and analyses.

Purpose of the Study:

  • To create a visualization tool for exploring the impact of parameter settings on the predictive performance of statistical methods.
  • To enable researchers to identify optimal parameter configurations for specific epidemiological study designs.

Main Methods:

  • Performance measures including sensitivity, specificity, AUC, MAP, and P(k) were calculated for various parameter settings.
  • Multiple regression analyses were conducted to assess the main effects of parameters on performance measures across test cases and subgroups.
  • Heatmaps were generated using standardized coefficients (t-statistics) to visualize the impact of parameter settings on performance measures.

Main Results:

  • Heatmaps effectively illustrate the influence of different parameter settings on method performance.
  • The visualization tool facilitates the exploration of design and analysis options for evaluating drug-outcome relationships.
  • Heatmaps also aid in identifying and understanding potential data issues affecting study outcomes.

Conclusions:

  • Statistical visualization using heatmaps provides a valuable method for summarizing and presenting the performance of epidemiological study methods.
  • Heatmaps enable efficient exploration of parameter settings, aiding in the optimization of method performance characteristics.
  • This approach helps researchers understand method performance in relation to data limitations and specific study contexts.